Laboratóio de Modelagem Molecular, Instituto de Química Orgânica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Instituto de Criminalística, Tocantins, Brazil.
Sci Rep. 2017 Nov 22;7(1):16011. doi: 10.1038/s41598-017-16197-5.
Dengue is an important infectious disease that presents high incidence and yields a relevant number of fatal cases (about 20,000) every year worldwide. Despite its epidemiological relevance, there are many knowledge gaps concerning dengue pathogenesis, especially with regards to the circumstances that drive a mild clinical course to a severe disease. In this work, we investigated the participation of high mobility group box 1 (HMGB1), an important modulator of inflammation, in dengue fatal cases. Histopathological and ultrastructural analyses revealed that liver, lung and heart post-mortem samples were marked by tissue abnormalities, such as necrosis and apoptotic cell death. These observations go in line with an HMGB1-mediated response and raised concerns regarding the participation of this cytokine in promoting/perpetuating inflammation in severe dengue. Further experiments of immunohistochemistry (IHC) showed increased expression of cytoplasmic HMGB1 in dengue-extracted tissues when compared to non-dengue controls. Co-staining of DENV RNA and HMGB1 in the host cell cytoplasm, as found by in situ hybridization and IHC, confirmed the virus specific induction of the HMGB1-mediated response in these peripheral tissues. This report brings the first in-situ evidence of the participation of HMGB1 in severe dengue and highlights novel considerations in the development of dengue immunopathogenesis.
登革热是一种重要的传染病,其发病率高,每年在全球范围内导致大量死亡病例(约 2 万例)。尽管它具有流行病学意义,但关于登革热发病机制仍存在许多知识空白,特别是在导致轻症向重症疾病发展的情况下。在这项工作中,我们研究了高迁移率族蛋白 B1(HMGB1)在登革热致死病例中的参与情况。组织病理学和超微结构分析表明,肝脏、肺脏和心脏的尸检样本存在组织异常,如坏死和凋亡细胞死亡。这些观察结果与 HMGB1 介导的反应一致,并引起了对这种细胞因子在促进/延续重症登革热炎症中的参与的关注。免疫组织化学(IHC)的进一步实验表明,与非登革热对照组相比,从登革热中提取的组织中 HMGB1 的细胞质表达增加。原位杂交和 IHC 显示,在宿主细胞质中 DENV RNA 和 HMGB1 的共染色证实了病毒特异性诱导了这些外周组织中的 HMGB1 介导的反应。本报告首次提供了 HMGB1 在重症登革热中的参与的体内证据,并强调了登革热免疫发病机制发展中的新考虑因素。